BRIEF-Ablynx achieves second milestone in immuno-oncology collaboration
* ABLYNX ACHIEVES SECOND MILESTONE IN IMMUNO-ONCOLOGY COLLABORATION WITH MERCK & CO. , INC., KENILWORTH, NEW JERSEY, USA
March 15 Altius Minerals Corp
* Altius reports third quarter financial results; declares quarterly dividend
* Q3 loss per share c$1.55
* Q3 revenue c$14.54 million Source text for Eikon: Further company coverage:
* Sanofi and Regeneron announce approval of Kevzara(®) (sarilumab) to treat adult patients with moderately to severely active rheumatoid arthritis in the European Union
TOKYO, June 27 Japanese auto parts maker Takata Corp apologised on Tuesday to victims of its faulty air bags linked to at least 16 deaths and 180 injuries around the world.